We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...

In a report released today, Joon Lee from Truist Financial reiterated a Buy rating on Catalyst Pharma (CPRX – Research Report). The company’s ...

Eli Lilly just scored a major win with its Phase 3 BRAVE-AA-PEDS study. The trial confirmed baricitinib's effectiveness in ...

(Sharecast News) - London stocks had extended gains by midday on Friday as investors mulled an unexpected contraction in the UK economy in January. The FTSE was up 0.6% at 8,593.51 .

The stock's fall snapped a two-day winning streak.

Financially, Annexon has a strong cash position, providing a runway of 5-8 quarters, but the stock trades almost at cash due ...

The $230-billion stablecoin market is seeing rapid adoption, especially as yield-bearing options become available.

Citi said SMid biotech sentiment has been more challenged than expected in early 2025, largely due to investor focus on ...

Citi initiated coverage of Kiniksa (KNSA) with a Buy rating and $40 price target Healthcare policy remains a key biopharma sector uncertainty ...

This was the stock's second consecutive day of gains.

In the US, healthcare expenditures and costs have been increasing. According to the Centers for Medicare & Medicaid Services, ...

Shri Amit Agrawal highlighted the rapid expansion of the sector, emphasizing India’s growing role in research and innovation.